Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
1,044
Views
3
CrossRef citations to date
0
Altmetric
Coronavirus – Research Article

Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5–11 years: Results from an active pharmacovigilance study in central Italy

Giancarlo Ripabellia Department of Medicine and Health Sciences “Vincenzo Tiberio”, University of Molise, Campobasso, Italy;b School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9953-7769View further author information
ORCID Icon,
Michela Lucia Sammarcoa Department of Medicine and Health Sciences “Vincenzo Tiberio”, University of Molise, Campobasso, ItalyView further author information
,
Antonio D’Amicob School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, ItalyView further author information
,
Roberta De Donab School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, ItalyView further author information
,
Mariagrazia Iafigliolab School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, ItalyView further author information
,
Albino Parenteb School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, ItalyView further author information
,
Nicandro Sampratib School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, ItalyView further author information
,
Arturo Santagatab School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, ItalyView further author information
,
Carmen Adessob School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, ItalyView further author information
,
Anna Nataleb School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, ItalyView further author information
,
Michela Anna Di Palmab School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, ItalyView further author information
,
Fabio Cannizzarob School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, ItalyView further author information
,
Roberto Romanoc Antonio Cardarelli Hospital, Azienda Sanitaria Regionale del Molise, Campobasso, ItalyView further author information
,
Antonietta Liciancic Antonio Cardarelli Hospital, Azienda Sanitaria Regionale del Molise, Campobasso, ItalyView further author information
&
Manuela Tamburroa Department of Medicine and Health Sciences “Vincenzo Tiberio”, University of Molise, Campobasso, ItalyView further author information
 show all
Article: 2126668 | Received 04 Jul 2022, Accepted 16 Sep 2022, Published online: 31 Oct 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Giancarlo Ripabelli, Angelo Salzo & Manuela Tamburro. (2023) Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5–11 years: Author’s reply to correspondence. Human Vaccines & Immunotherapeutics 19:1.
Read now
Rujittika Mungmunpuntipantip & Viroj Wiwanitkit. (2022) Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence. Human Vaccines & Immunotherapeutics 18:7.
Read now

Articles from other publishers (1)

. (2022) Pfizer-BioNTech COVID-19 vaccination in children: no serious AEs. Reactions Weekly 1932:1, pages 12-12.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.